Select Medical (NYSE:SEM) Stock Rating Lowered by StockNews.com

Select Medical (NYSE:SEM) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Monday.

A number of other research analysts have also recently commented on the stock. Royal Bank of Canada upped their target price on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th.

Select Medical Trading Down 1.0 %

NYSE:SEM traded down $0.19 on Monday, hitting $18.80. The stock had a trading volume of 975,573 shares, compared to its average volume of 703,268. The company has a fifty day moving average price of $28.01 and a two-hundred day moving average price of $32.62. Select Medical has a 1-year low of $18.02 and a 1-year high of $40.98. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a market cap of $2.43 billion, a price-to-earnings ratio of 8.79, a PEG ratio of 0.39 and a beta of 1.43.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same period in the prior year, the business posted $0.46 earnings per share. The firm’s revenue for the quarter was up 5.7% compared to the same quarter last year. Equities research analysts expect that Select Medical will post 1.97 earnings per share for the current fiscal year.

Insider Buying and Selling at Select Medical

In other Select Medical news, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total value of $99,530.55. Following the sale, the vice president now owns 30,356 shares of the company’s stock, valued at $605,602.20. This trade represents a 14.12 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the transaction, the director now owns 22,000 shares of the company’s stock, valued at $463,980. The trade was a 59.26 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is currently owned by corporate insiders.

Institutional Trading of Select Medical

Several hedge funds have recently added to or reduced their stakes in the company. Quarry LP purchased a new position in Select Medical in the third quarter valued at approximately $30,000. Canada Pension Plan Investment Board acquired a new position in shares of Select Medical in the 2nd quarter valued at $39,000. DekaBank Deutsche Girozentrale purchased a new position in shares of Select Medical in the 2nd quarter valued at $60,000. GAMMA Investing LLC raised its stake in Select Medical by 16.6% during the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock worth $81,000 after acquiring an additional 330 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB purchased a new stake in Select Medical in the third quarter valued at $81,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.